July 6, 2017/Cancer

How Are You Achieving Reductions in Time to Treat for Colorectal, Breast and GI Cancers?

The short answer from Chairman Conor Delaney, MD, PhD

15-DDI-2421-Delaney-650×450-CQD

Q: Time to treat is on the rise nationally ― and it’s associated with worsened survival, according to a recent study presented at ASCO. How have you achieved reductions in time to treat for colorectal, breast and GI cancers and what efforts are ongoing?

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

A: Time to treat for cancer patients is a huge focus for us at the Digestive Disease & Surgery Institute.

While there is surprisingly little evidence showing that a longer time to treat makes cancer outcomes worse, we are all concerned that any unnecessary wait can only be a bad thing. Perhaps more important, any wait is obviously very distressing for a patient who has recently been diagnosed with a condition that’s stressful for them, their family and their friends.

We’re putting a lot of effort into time to treat at Cleveland Clinic. We are optimizing physicians’ schedules and providing them with the proper support so we can give our patients better access to our care. For many services, we also have weekly or more frequent “huddles,” in which physicians, nurses and our navigation team members come together to get patients in with the right physician or surgeon. The goal? To find where patients best fit into the schedule, allowing them the quickest access to the most suitable and personalized treatment.

Advertisement

In addition, we have multidisciplinary tumor boards for all of the cancers that we treat at Cleveland Clinic. Every cancer patient has his or her case discussed by a team of physicians, surgeons, oncologists, radiologists and radiation oncologists who come up with an individualized treatment plan.

These tumor boards allows us to track the date of diagnosis and actively manage the patient’s pathway through any necessary investigations or testing before treatment is initiated. It also ensures our whole team is on the same page about coordinating treatment.

The result? A patient-centered system that individualizes and perfects the right treatment pathway for each patient ― all while moving the patient through the pathway of testing and treatment as expediently as possible.

Advertisement

— Conor Delaney, MD, PhD

Chairman, Digestive Disease & Surgery Institute Cleveland Clinic

Related Articles

Women's health physician
April 16, 2024/Cancer
Watching Out for Primary Ovarian Insufficiency

An underdiagnosed condition in patients with cancer

Fluorescent imaging during small bowel surgery
April 11, 2024/Cancer/Surgical Oncology
Fluorescence Imaging Augments Surgical Inspection and Palpation for Small Bowel Carcinoid Tumors

Study demonstrates superior visualization of occult primary lesions

microwave ablation of liver tumor
150-Watt, Single-Antenna Microwave Ablation System Demonstrates Safety and Efficacy

New device offers greater tumor control for malignant liver lesions

viral-induced cancer
April 3, 2024/Cancer
Mechanism of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) May Serve as Clue to More Effective Treatment

Cleveland Clinic researchers discover what drives – and what may halt – virus-induced cancer

Dr. Mukherjee at Cleveland Clinic
April 1, 2024/Cancer/Blood Cancers
Many Patients with “Indolent” Systemic Mastocytosis Experience Rapid Decline and Lower Survival

First-ever U.S. population-level retrospective analysis reveals many patients with systemic mastocytosis need faster intervention

Cleveland Clinic physiatrist
March 22, 2024/Cancer/Innovations
The Vital Role of Oncology Rehabilitation (Podcast)

New program provides prehabilitation and rehabilitation services to help patients with cancer maintain and regain function

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Ad